<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Clinics (Sao Paulo)</journal-id><journal-id journal-id-type="iso-abbrev">Clinics (Sao Paulo)</journal-id><journal-title-group><journal-title>Clinics</journal-title></journal-title-group><issn pub-type="ppub">1807-5932</issn><issn pub-type="epub">1980-5322</issn><publisher><publisher-name>Hospital das Cl&#x000ed;nicas da Faculdade de Medicina da Universidade de S&#x000e3;o Paulo</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28226031</article-id><article-id pub-id-type="pmc">5251200</article-id><article-id pub-id-type="doi">10.6061/clinics/2017(01)07</article-id><article-id pub-id-type="publisher-id">cln_72p36</article-id><article-categories><subj-group subj-group-type="heading"><subject>Clinical Science</subject></subj-group></article-categories><title-group><article-title>Evaluation of clinical and laboratory markers of cardiometabolic risk in overweight and obese children and adolescents</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>da Cunha Palhares</surname><given-names>Helo&#x000ed;sa Marcelina</given-names></name><xref ref-type="aff" rid="af1-cln_72p36">I</xref><xref ref-type="corresp" rid="c1-cln_72p36">*</xref></contrib><contrib contrib-type="author"><name><surname>da Silva</surname><given-names>Adriana Paula</given-names></name><xref ref-type="aff" rid="af1-cln_72p36">I</xref></contrib><contrib contrib-type="author"><name><surname>Resende</surname><given-names>Daniela Cristina Silva</given-names></name><xref ref-type="aff" rid="af1-cln_72p36">I</xref></contrib><contrib contrib-type="author"><name><surname>de Ara&#x000fa;jo Pereira</surname><given-names>Gilberto</given-names></name><xref ref-type="aff" rid="af2-cln_72p36">II</xref></contrib><contrib contrib-type="author"><name><surname>Rodrigues-J&#x000fa;nior</surname><given-names>Virmondes</given-names></name><xref ref-type="aff" rid="af3-cln_72p36">III</xref></contrib><contrib contrib-type="author"><name><surname>de F&#x000e1;tima Borges</surname><given-names>Maria</given-names></name><xref ref-type="aff" rid="af1-cln_72p36">I</xref></contrib><aff id="af1-cln_72p36"><label>I</label>Divis&#x000e3;o de Endocrinologia, Faculdade de Medicina, Universidade Federal do Tri&#x000e2;ngulo Mineiro, Uberaba/MG, Brazil</aff><aff id="af2-cln_72p36"><label>II</label>Divis&#x000e3;o de Enfermagem e Educa&#x000e7;&#x000e3;o Comunit&#x000e1;ria, Faculdade de Medicina, Universidade Federal do Tri&#x000e2;ngulo Mineiro, Uberaba/MG, Brazil</aff><aff id="af3-cln_72p36"><label>III</label>Divis&#x000e3;o de Imunologia, Faculdade de Medicina, Universidade Federal do Tri&#x000e2;ngulo Mineiro, Uberaba/MG, Brazil</aff></contrib-group><author-notes><corresp id="c1-cln_72p36">*Corresponding author. E-mail: <email>helomcp@terra.com.br</email></corresp></author-notes><pub-date pub-type="epub"><month>1</month><year>2017</year></pub-date><pub-date pub-type="ppub"><month>1</month><year>2017</year></pub-date><volume>72</volume><issue>1</issue><fpage>36</fpage><lpage>43</lpage><history><date date-type="received"><day>14</day><month>7</month><year>2016</year></date><date date-type="rev-recd"><day>23</day><month>9</month><year>2016</year></date><date date-type="accepted"><day>24</day><month>10</month><year>2016</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2017 CLINICS</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>) which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>OBJECTIVE:</title><p>This study analyzed the frequency of cardiometabolic risk markers and metabolic syndrome occurrence in overweight and obese children and adolescents.</p></sec><sec><title>METHODS:</title><p>The participants included 161 overweight (n=65) and obese (n=96) individuals aged between 5 and 19 years. Clinical markers were assessed (body mass index, body fat percentage, waist circumference, acanthosis, systolic and diastolic blood pressures, laboratory parameters [glucose, insulin, cholesterol (total and fractions) and triglyceride levels and homeostasis model assessment of insulin resistance (HOMA-IR) index] and leptin and adiponectin levels). The frequency of changes, odds ratios and correlations among markers were determined. Metabolic syndrome was assessed according to International Diabetes Federation criteria.</p></sec><sec><title>RESULTS:</title><p>A high frequency of acanthosis (51.6%); increased waist circumference (45.4%), systolic blood pressure / diastolic blood pressure (8.1% / 9.3%), glucose (10%), insulin (36.9%) and HOMA-IR (44.3%) values; and reduced high-density lipoprotein levels (47.2%) were observed. Leptin levels were increased in 95% of obese and in 66% of overweight subjects. Adiponectin was decreased in 29.5% of obese and in 34% of overweight subjects. An odd ratio analysis revealed a greater probability of increased waist circumference (9.0), systolic blood pressure (4.1), triglyceride (2.3) and insulin (2.9) levels and HOMA-IR (3.0) in the obese group than in the overweight group. The clinical and laboratory parameters and leptin levels exhibited significant correlations, whereas adiponectin was negatively correlated with systolic blood pressure. The occurrence rate of metabolic syndrome was 13.6%.</p></sec><sec><title>CONCLUSIONS:</title><p>The high frequency of changes in clinical, laboratory and adipokine markers indicates the need for early interventions aimed at preventing cardiometabolic complications in adulthood.</p></sec></abstract><kwd-group><kwd>Cardiometabolic Risk</kwd><kwd>Children</kwd><kwd>Adolescents</kwd><kwd>Overweight</kwd><kwd>Obesity</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>Childhood obesity is widely distributed in developed and developing countries, and the prevalence of excess body weight has increased progressively in the past 30 years, thus becoming an important public health problem worldwide <xref rid="b1-cln_72p36" ref-type="bibr">1</xref>. According to data from the World Obesity Federation, 29.5% of all female and 29.7% of all male children and adolescents exhibited excess body weight, including obesity, in the United States between 2013 and 2014 <xref rid="b2-cln_72p36" ref-type="bibr">2</xref>. In Brazil, data from the Family Budget Surveys (Pesquisa de Or&#x000e7;amentos Familiares &#x02013; POF) from 2008 to 2009 show that 33.5% of children between 5 and 9 years of age and 20.5% of adolescents aged 10 to 19 years exhibited excess body weight, among whom 14.3% and 4.9% were classified as obese, respectively <xref rid="b3-cln_72p36" ref-type="bibr">3</xref>. The Southeast region of Brazil exhibited the highest assessments of excess body weight, namely, 39% in children and 22.6% in adolescents <xref rid="b3-cln_72p36" ref-type="bibr">3</xref>.</p><p>Obesity in childhood and adolescence is associated with a series of comorbidities, including dyslipidemia, systemic hypertension and changes in glucose metabolism, which in concert with abdominal obesity, define metabolic syndrome. The persistence of obesity is an important risk factor for the development of type 2 diabetes mellitus (DM) and cardiovascular disease (CVD) in adults <xref rid="b1-cln_72p36" ref-type="bibr">1</xref>,<xref rid="b4-cln_72p36" ref-type="bibr">4</xref>,<xref rid="b5-cln_72p36" ref-type="bibr">5</xref>.</p><p>Insulin resistance is an important condition that is associated with overweight and obesity, and studies have indicated that affected individuals exhibit a higher predisposition for the development of metabolic disorders in adulthood <xref rid="b1-cln_72p36" ref-type="bibr">1</xref>,<xref rid="b6-cln_72p36" ref-type="bibr">6</xref>. An excess of body fat not only results in metabolic changes in adipose tissue and the induction of insulin resistance but also leads to endothelial dysfunction via pro-inflammatory and pro-thrombotic effects due to the action of pro-inflammatory cytokines and adipokines <xref rid="b7-cln_72p36" ref-type="bibr">7</xref>. Leptin and adiponectin, which are the primary adipokines produced by adipose tissue, play important roles in the cardiometabolic outcomes associated with excess body weight <xref rid="b7-cln_72p36" ref-type="bibr">7</xref>,<xref rid="b8-cln_72p36" ref-type="bibr">8</xref>.</p><p>In Brazil, studies assessing cardiometabolic risk markers in overweight children and adolescents show high frequencies of changes in waist circumference (WC), blood pressure, dyslipidemia, insulin resistance and adipokine levels <xref rid="b6-cln_72p36" ref-type="bibr">6</xref>,<xref rid="b9-cln_72p36" ref-type="bibr">9</xref>,<xref rid="b10-cln_72p36" ref-type="bibr">10</xref>,<xref rid="b11-cln_72p36" ref-type="bibr">11</xref>.</p><p>The search for effective measures to identify obese pediatric patients at a higher risk of developing metabolic and cardiovascular complications constitutes a promising strategy in the prevention of the comorbidities of early obesity <xref rid="b6-cln_72p36" ref-type="bibr">6</xref>. Therefore, the objective of the present study was to analyze the family history of excess body weight as well as the clinical, laboratory and adipokine markers of cardiometabolic risk and the occurrence of metabolic syndrome in overweight and obese children and adolescents recruited from public schools in a population study in the city of Uberaba, Minas Gerais, Southeast Brazil.</p></sec><sec sec-type="materials|methods"><title>MATERIALS AND METHODS</title><p>The present work is a descriptive and analytical prospective cross-sectional study that considered a population of 364 overweight and obese children and adolescents (5 to 19 years of age) from public schools of the Municipality of Uberaba, Minas Gerais, Brazil, who had participated in a previous study on the prevalence of overweight status and obesity <xref rid="b12-cln_72p36" ref-type="bibr">12</xref>. A total of 161 children and adolescents agreed to participate in the study.</p><p>To achieve the proposed objectives, the clinical history of the respective parents, such as the presence of excess body weight, DM, hypertension and dyslipidemia, was obtained by means of an inquiry.</p><sec><title>Clinical Markers</title><p>Clinical markers were determined by assessing the nutritional status of the subjects, which included weight, height, skinfolds and WC, and by calculating the body mass index (BMI) using standardized procedures <xref rid="b13-cln_72p36" ref-type="bibr">13</xref>,<xref rid="b14-cln_72p36" ref-type="bibr">14</xref>. According to the criteria proposed by the World Health Organization (WHO, 2006) <xref rid="b13-cln_72p36" ref-type="bibr">13</xref>, the nutritional state of all the participants was classified based on the BMI z-score (z-BMI), which was calculated with WHO-Anthro Plus 2007 software, Geneva, Switzerland. Individuals were categorized as overweight (+1 &#x02264; z-BMI &#x0003c; +2) or obese (z-BMI &#x02265; +2). The body fat percentage (BFP) was calculated using the sum of four skinfolds as the criterion as in the equations of Slaughter et al. <xref rid="b14-cln_72p36" ref-type="bibr">14</xref>, who measured triceps and subscapular skinfold thicknesses. WC was measured while the individual was in a standing position, midway between the lowest rib and the top of the iliac crest, at the end of a normal expiration, with a non-extensible tape measure with millimeter graduations. WC was considered high when the value was within or above the 90<sup>th</sup> percentile (P90) according to sex and age <xref rid="b15-cln_72p36" ref-type="bibr">15</xref>. Physical examinations also included a detailed evaluation of the skin with respect to clinical signs of insulin resistance, manifested by the presence of acanthosis nigricans, which was assessed visually in the neck, armpits and groin.</p><p>Systolic and diastolic blood pressures (SBP and DBP, respectively) were measured in the right arm, and the obtained values were classified according to sex, age and height following the criteria of the I Guideline for Preventing Atherosclerosis in Childhood and Adolescence (I Diretriz de Preven&#x000e7;&#x000e3;o da Aterosclerose na Inf&#x000e2;ncia e Adolesc&#x000ea;ncia) of the Brazilian Society of Cardiology <xref rid="b16-cln_72p36" ref-type="bibr">16</xref>.</p><p>The pubertal stage was evaluated by a single researcher and classified into pre-pubertal and pubertal, according to the criteria of Marshall and Tanner <xref rid="b17-cln_72p36" ref-type="bibr">17</xref>,<xref rid="b18-cln_72p36" ref-type="bibr">18</xref>.</p></sec><sec><title>Laboratory and Adipokine markers</title><p>Blood samples were collected after 10 h to 12 h of fasting via peripheral venipuncture to assess the levels of fasting glucose, insulin, total cholesterol, high- and low-density lipoprotein cholesterol (HDL-C and LDL-C, respectively), triglycerides (TGs), leptin and adiponectin. Specifically, serum levels of total cholesterol, HDL-C and TG were assessed by an enzymatic colorimetric assay, and fasting glucose levels were determined by a hexokinase enzymatic assay. All samples were processed in a COBAS 6000-analyzer module C501 (Roche-Hitachi). Serum LDL-C levels were calculated with the equation of Friedewald et al. <xref rid="b19-cln_72p36" ref-type="bibr">19</xref>. Insulin levels were measured by electrochemiluminescence (ECL) (COBAS 6000 analyzer, module C601, Roche-Hitachi). Finally, leptin levels were measured in duplicate by an enzyme-linked immunosorbent assay (ELISA) using a commercial kit from EMD Millipore, Millipore Corporation (Billerica, MA, USA), with reference values considered as a BMI of 18 to 25 kg/m<bold><sup>2</sup></bold>, i.e., 3.70 to 11.1 ng/mL for women and 2.0 to 5.6 ng/mL for men. Adiponectin levels were measured by an ELISA, employing a commercial kit provided by Abcam Inc. (Cambridge, USA) and expressed as ng/mL.</p><p>Metabolic changes were considered according to the I Guideline for Preventing Atherosclerosis in Childhood and Adolescence <xref rid="b16-cln_72p36" ref-type="bibr">16</xref>.</p><p>The homeostasis model assessment of insulin resistance (HOMA-IR) index was calculated by multiplying fasting plasma insulin (&#x000b5;U/mL) by fasting glucose (mmol/L), divided by 22.5. The cutoff point was &#x02265;2.5 for pre-pubertal <xref rid="b20-cln_72p36" ref-type="bibr">20</xref> and &#x02265;3.43 for pubertal individuals of both sexes <xref rid="b21-cln_72p36" ref-type="bibr">21</xref>. The TG/HDL-C ratio (TG/HDL-C) was calculated by dividing the serum TG level by the serum HDL-C level.</p></sec><sec><title>Characterization of metabolic syndrome</title><p>Metabolic syndrome was characterized according to the criteria proposed by the International Diabetes Federation (IDF) <xref rid="b22-cln_72p36" ref-type="bibr">22</xref>. Regarding the age range &#x0003c;10 years, the criteria of the IDF were adapted, i.e., metabolic syndrome was considered as a WC&#x02265;P90 associated with two of the following criteria: fasting glucose &#x02265;100 mg/dL, TG&#x02265;130 mg/dL, HDL-C&#x0003c;45 mg/dL and SBP or DBP&#x02265;P95, according to sex, age and height.</p></sec><sec><title>Statiscal Analysis</title><p>The data were subjected to a descriptive analysis based on absolute and percent frequencies and measures of centrality and dispersion.</p><p>The Kolmogorov-Smirnov test was used to analyze the normal distribution of numeric variables, and the homogeneity of variances between the groups was assessed with Levene&#x02019;s test.</p><p>In comparisons between two independent groups, Student&#x02019;s <italic>t</italic>-test was used for data with a normal distribution and homogeneity of variances, and the Mann-Whitney <italic>U</italic> test was used for data that did not meet the aforementioned criteria.</p><p>Categorical variables were compared using the Chi-squared (&#x003c7;<sup>2</sup>) test, and the odds ratio (OR) was calculated to evaluate the probability of a specific event occurring over another.</p><p>Correlations were analyzed with Pearson&#x02019;s or Spearman&#x02019;s tests, and multiple linear regression was used for the dependent variables leptin and adiponectin with clinical and laboratory parameters as the predictor variables.</p><p>The level of significance was set at 5%. Statistical analyses were performed with the software STATISTICA, Statsoft version 10 and R.</p></sec><sec><title>Ethical Aspects</title><p>The present study was approved by the Human Research Ethics Committee of the Federal University of Tri&#x000e2;ngulo Mineiro (Universidade Federal do Tri&#x000e2;ngulo Mineiro), under the number 2479, and all parents/legal guardians signed the informed consent form.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>Regarding the nutritional assessment of the studied population, 40.4% (65/161) were overweight, and 59.6% (96/161) were obese children and adolescents. Among the parents, 65.8% had excess body weight, 10.4% had DM, 32.5% had systemic arterial hypertension, and 19.5% had dyslipidemia.</p><p>In the overweight group, the mean age was of 12.6&#x000b1;3.4 years; 70.8% (46/65) were female, and 73.8% (48/65) were pubertal. In the obese group, the mean age was of 10.9&#x000b1;2.5 years; 59.4% (57/96) were female, and 51% (49/96) were pubertal (<xref rid="t1-cln_72p36" ref-type="table">Table 1</xref>). The overweight group had a significantly higher mean age (<italic>p</italic>=0.0002) and predominance of pubertal individuals (<italic>p</italic>=0.003) compared to the obese group. Furthermore, the obese group exhibited significantly higher BMI (kg/m<sup>2</sup>), z-BMI, BFP and WC values than the overweight group (<italic>p</italic>&#x0003c;0.0001), while there was no statistically significant difference between the groups in the mean SBP and DBP measurements (<xref rid="t1-cln_72p36" ref-type="table">Table 1</xref>).</p><p>The biochemical, hormone and adipokine profiles of the overweight and obese groups are described in <xref rid="t1-cln_72p36" ref-type="table">Table 1</xref>. The obese group exhibited significantly higher serum total cholesterol, LDL-C, TG, TG/HDL-C, insulin and HOMA-IR values. Regarding adipokines, serum leptin levels were significantly higher in the obese group and were above the adopted reference values in 95% of the obese group and 66% of the overweight group. Adiponectin was not detected in the serum of all of the studied individuals, given that concentrations were below the detection limit of the applied method in 34% of the overweight group and 29.5% of the obese group, with no statistically significant difference between the groups (<xref rid="t1-cln_72p36" ref-type="table">Table 1</xref>).</p><p>In the total sample (n=161), the WC was increased (&#x02265;P90) in 73 (45.4%) individuals, and the SBP and DBP were increased(&#x02265;P95)in 13 (8.1%)and 15 (9.3%)individuals, respectively (<xref rid="t2-cln_72p36" ref-type="table">Table 2</xref>).</p><p>Acanthosis nigricans was present in 51.6% of the total sample (83/161) and was significantly higher in the obese group (62/96, 64.6%) than in the overweight group (21/65, 32.3%) (<italic>p</italic>&#x0003c;0.0001; <xref rid="t2-cln_72p36" ref-type="table">Table 2</xref>). The obese group also exhibited a significantly higher percentage of cervical (61.5% <italic>versus</italic> 18.5%) and axillary acanthosis (46.9% <italic>versus</italic> 21.5%) than the overweight group (<xref rid="t2-cln_72p36" ref-type="table">Table 2</xref>).</p><p>According to the OR analysis, the probability of increased WC was 9.0 times higher (4.1-19.4) in the obese group than in the overweight group, while the probability of increased SBP was 4.1 times higher (0.9-19.0) and that of the presence of acanthosis nigricans was 3.8 (2.0-7.4) times higher in the obese group (<xref rid="t2-cln_72p36" ref-type="table">Table 2</xref>).</p><p>Changes in the laboratory parameters with respect to the reference data ranged from 10.0% (regarding glucose) up to 47.2% (regarding HDL-C) of the studied population. There was a significantly higher ratio of obese children and adolescents with changes in TG (29.2%; <italic>p</italic>=0.04), insulin (46.3%; <italic>p</italic>=0.002) and HOMA-IR index (54.7 %; <italic>p</italic>=0.001) (<xref rid="t3-cln_72p36" ref-type="table">Table 3</xref>).</p><p>The OR analysis revealed a 2.3 (1.0-5.0) times greater probability of exhibiting increased levels of serum TG, a 2.9 (1.4-5.8) times greater probability of increased insulin levels and a 3.0 (1.5-5.9) times greater probability for altered HOMA-IR values in the obese group compared with the overweight group (<xref rid="t3-cln_72p36" ref-type="table">Table 3</xref>).</p><p>The simple linear correlation coefficients between the clinical, laboratory and adipokine parameters are presented in <xref rid="t4-cln_72p36" ref-type="table">Table 4</xref>. All the parameters were significantly correlated with leptin, whereas adiponectin only exhibited a significant negative correlation with SBP. Based on these significant correlations, a multiple linear regression model was applied and adjusted for age, sex, pubertal staging, BMI, z-BMI, WC, BFP, SBP, DBP, HDL-C, TG, glucose, insulin and HOMA-IR value, considering leptin as the dependent variable. In this model, sex (<italic>p</italic>&#x0003c;0.0001), WC (<italic>p</italic>=0.004), BFP (<italic>p</italic>=0.009) and pubertal stage (<italic>p</italic>=0.04) explained 63% of the changes in the serum leptin levels (r<sup>2</sup>=0.63; leptin = -6711 + 8.39 sex +0.38 WC + 0.27 BFP &#x02013; 3.92 pubertal stage). The same multiple linear regression analysis was performed with SBP as the predictor and adiponectin as the dependent variable; however, SBP exhibited no statistical significance.</p><p>In the analysis of the clinical and laboratory data, the occurrence rate of metabolic syndrome, as defined according to the adopted criteria, was 13.6% (22/161), among which there was one overweight and 21 obese individuals and 10 children under 10 years of age. Of note, children with and without metabolic syndrome exhibited similarities regarding sex, age and pubertal stage. Furthermore, all parameters in the clinical and metabolic profiles of the individuals with metabolic syndrome were significantly increased, except for LDL-C and glucose, which exhibited no statistically significant difference (<xref rid="t5-cln_72p36" ref-type="table">Table 5</xref>).</p><p>The analysis according to the number of criteria used to characterize metabolic syndrome revealed that 32.3% (52/161) of the participants presented with none of the criteria, whereas 30.4% (49/161) presented with one criterion, 23.6% (38/161) presented with two, 11.2% (18/161) presented with three, and 2.5% (4/161) presented with four of the criteria for metabolic syndrome.</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>In view of the growing body of studies on the risk factors for CVD and type 2 DM, the failure to identify and act upon these risk factors in childhood and adolescence entails the sustainment of the above pathologies into adulthood, thus increasing the probability of adverse outcomes.</p><p>In the present study, we found a high frequency (65.8%) of excess body weight reported by parents, and studies indicate that the presence of obesity in parents seems to be an important risk factor for the development of early obesity in childhood, resulting from the sum of genetic influences and the influence of the parent&#x02019;s lifestyle on their children <xref rid="b23-cln_72p36" ref-type="bibr">23</xref>. In addition to obesity, a family history of DM, hypertension, dyslipidemia and early atherosclerotic disease are risk factors for CVD and DM in offspring <xref rid="b1-cln_72p36" ref-type="bibr">1</xref>,<xref rid="b23-cln_72p36" ref-type="bibr">23</xref>.</p><p>Considering that the probability of permanent obesity in adulthood is 20% to 50% in cases when obesity occurs before sexual maturity and 50% to 70% in cases in which obesity occurs after the onset of puberty, the nutritional assessment of obese children and adolescents should clearly take into account chronological age and degree of sexual maturity <xref rid="b6-cln_72p36" ref-type="bibr">6</xref>. We found obesity in underage children and adolescents in equal proportions with regard to sexual maturity (49% of the pre-pubertal and 51% of the pubertal individuals). Notably, these are alarming data, and early intervention is required to avoid the comorbidities associated with obesity.</p><p>In the analysis of the studied population, we found a high frequency of increased WC (45.4%), which was more predominant in the obese group; this group also exhibited a higher BFP (total adiposity). These findings corroborate other Brazilian studies showing that increased BMI and body adiposity, particularly central adiposity, potentiate the emergence of metabolic risk factors <xref rid="b6-cln_72p36" ref-type="bibr">6</xref>,<xref rid="b9-cln_72p36" ref-type="bibr">9</xref>,<xref rid="b24-cln_72p36" ref-type="bibr">24</xref>. In a study of obese adolescents in S&#x000e3;o Paulo state, Brazil, Masquio et al. <xref rid="b10-cln_72p36" ref-type="bibr">10</xref> found that WC is positively correlated with the number of metabolic syndrome parameters, inflammatory biomarkers and visceral fat and is a simple and practical method to assess visceral adiposity. Furthermore, data from the Bogalusa Heart study <xref rid="b25-cln_72p36" ref-type="bibr">25</xref> show a high cardiometabolic risk for children with abdominal obesity and excess or normal body weight compared to children with excess body weight devoid of excess abdominal fat. In the present study, the obese group had a nine-fold greater probability of exhibiting an increased WC compared with the overweight group, thus rendering WC an important practical clinical measure to estimate cardiometabolic risk.</p><p>In a study of Brazilian adolescents ranging in age from 10 to 16 years, Moser et al. <xref rid="b26-cln_72p36" ref-type="bibr">26</xref> have shown that triceps skin-fold thickness and BMI represent anthropometric indicators independently associated with blood pressure above P90, irrespective of abdominal adiposity and sexual maturity. Furthermore, a high BMI increased the risk of high blood pressure nearly three-fold among students with excess body weight compared with eutrophic controls. Morrison et al. <xref rid="b5-cln_72p36" ref-type="bibr">5</xref> have shown that maintaining a normal BMI from childhood up to adulthood is a significant negative risk factor for CVD in adulthood and also that high blood pressure throughout childhood up to adulthood increases the probability of exhibiting type 2 DM. In the present study, two groups with altered BMI values were compared, and the mean blood pressure did not differ between the groups. However, the obese group exhibited a 4 times greater probability of increased blood pressure than the overweight group. In addition, we found a positive correlation between BMI, WC and blood pressure, thus reinforcing the classification of BMI and WC as anthropometric markers of cardiovascular risk.</p><p>Studies indicate that the process of atherosclerosis begins in childhood and is related to obesity and cardiovascular risk factors, such as hypertension, dyslipidemias and changes in glucose metabolism <xref rid="b10-cln_72p36" ref-type="bibr">10</xref>,<xref rid="b11-cln_72p36" ref-type="bibr">11</xref>,<xref rid="b27-cln_72p36" ref-type="bibr">27</xref>. In adolescents, carotid intima-media thickness, which is considered a subclinical marker of atherosclerosis, has been found to be positively correlated with parameters of metabolic syndrome, including LDL-C, low HDL-C, TG, subcutaneous abdominal fat volume, visceral fat volume and blood pressure <xref rid="b27-cln_72p36" ref-type="bibr">27</xref>,<xref rid="b28-cln_72p36" ref-type="bibr">28</xref>. In the present study, changes in lipid metabolism were highly relevant, and the obese group exhibited higher means of total cholesterol, LDL-C, TG and TG/HDL-C compared with the overweight group. In the Princeton Lipid Research Clinics (LRC) follow-up study, Morrison et al. <xref rid="b5-cln_72p36" ref-type="bibr">5</xref> showed that individuals with high TG levels from childhood up to adulthood exhibited an increase in cardiovascular events during adulthood. This result reveals the importance of early diagnosis and treatment of metabolic changes. In support of this approach, other follow-up studies have shown that overweight and obese children who became non-obese adults normalized the risks of dyslipidemia, hypertension and subclinical atherosclerosis in adulthood, thus behaving like individuals who had never been obese <xref rid="b29-cln_72p36" ref-type="bibr">29</xref>.</p><p>An increase in adipose tissue during childhood is likely an initial event in the development of alterations in glucose metabolism and represents a trigger for insulin resistance. Therefore, the search for clinical and laboratory indicators of insulin resistance in obese children is necessary <xref rid="b20-cln_72p36" ref-type="bibr">20</xref>. We found a high prevalence of acanthosis nigricans, a clinical marker of insulin resistance, and changes in glycemia, fasting insulinemia and the HOMAR-IR index values in the studied population, as previously reported in other studies of Brazilian children and adolescents <xref rid="b6-cln_72p36" ref-type="bibr">6</xref>,<xref rid="b10-cln_72p36" ref-type="bibr">10</xref>,<xref rid="b11-cln_72p36" ref-type="bibr">11</xref>. These changes were predominant in the obese group, except for fasting glycemia, which exhibited similar changes in both groups. The Bogalusa Heart study <xref rid="b30-cln_72p36" ref-type="bibr">30</xref>, a longitudinal study, has shown that individuals with persistently high insulin levels also exhibit higher BMI, blood pressure and levels of total cholesterol, LDL-C, TG and glucose and lower HDL-C levels compared with individuals with lower insulin levels. Furthermore, persistently high insulin levels over time were associated with a higher probability of developing hypertension, dyslipidemia and obesity in young adults. In a cohort study of white and black girls who had a diagnosis of metabolic syndrome and insulin levels within the upper quartile at 10 years of age, Morrisson et al. <xref rid="b31-cln_72p36" ref-type="bibr">31</xref> found a high percentage of evolution into altered fasting glucose and type 2 DM 14 years later. This finding is in agreement with another study on childhood cardiometabolic risk factors and evolution into type 2 DM after 25 to 30 years <xref rid="b32-cln_72p36" ref-type="bibr">32</xref>. A significant positive association has also been found between BMI and insulin, HOMA-IR values and BMI, HOMA-IR values and WC as well as HOMA-IR values and TG among children and adolescents <xref rid="b6-cln_72p36" ref-type="bibr">6</xref>,<xref rid="b33-cln_72p36" ref-type="bibr">33</xref>, thus further corroborating the results of the present study, which show a three-fold greater probability of obesity associated with increased insulin levels and HOMA-IR values.</p><p>Adipokines secreted by visceral adipose tissue are associated with components of metabolic syndrome <xref rid="b4-cln_72p36" ref-type="bibr">4</xref>,<xref rid="b7-cln_72p36" ref-type="bibr">7</xref>,<xref rid="b10-cln_72p36" ref-type="bibr">10</xref>. Studies on obese children, adolescents and adults have evidenced a direct correlation between leptin and adiposity markers (BMI, WC and BFP) and with glucose, insulin and HOMA-IR values <xref rid="b8-cln_72p36" ref-type="bibr">8</xref>,<xref rid="b9-cln_72p36" ref-type="bibr">9</xref>,<xref rid="b34-cln_72p36" ref-type="bibr">34</xref>. Additionally, studies on adiponectin have shown an inverse correlation with BMI, WC, insulin, HOMA-IR and TG values <xref rid="b8-cln_72p36" ref-type="bibr">8</xref>,<xref rid="b35-cln_72p36" ref-type="bibr">35</xref>. In the present study, we found a positive correlation between leptin and adiposity markers, blood pressure, insulin and HOMA-IR values. Adiponectin was not significantly correlated with adiposity markers; however, several samples were below the detection limits of the method, and we suggest the presence of hypoadiponectinemia in these patients, which has already been documented in the literature <xref rid="b8-cln_72p36" ref-type="bibr">8</xref>,<xref rid="b9-cln_72p36" ref-type="bibr">9</xref>,<xref rid="b35-cln_72p36" ref-type="bibr">35</xref>. Studies have also shown that adiponectin levels decrease with age and are higher in girls <xref rid="b8-cln_72p36" ref-type="bibr">8</xref>,<xref rid="b9-cln_72p36" ref-type="bibr">9</xref>. In the present work, we suggest that there was no difference between the groups, given that the overweight children were older but were predominantly female.</p><p>An increased prevalence of metabolic syndrome has accompanied the global epidemic of obesity. This increase has also occurred in the pediatric age range, and as previously observed, components of metabolic syndrome are already present at early ages. The definition of the criteria for metabolic syndrome in children and adolescents is still prone to limitations and difficulties with respect to the uniformity of the criteria used for diagnosis. However, adaptations have been used in the literature <xref rid="b4-cln_72p36" ref-type="bibr">4</xref>,<xref rid="b6-cln_72p36" ref-type="bibr">6</xref>,<xref rid="b20-cln_72p36" ref-type="bibr">20</xref>. In the present casuistic, we found a 13.6% occurrence rate of metabolic syndrome, and even though the criteria of the IDF are not applicable to children below 10 years of age, we found a significant number of children who met these adapted criteria. Thus, regardless of the definition of metabolic syndrome, the high percentage of individuals with at least one criterion indicates the need for early intervention regarding the detected risk factors.</p><p>The risk factors identified among obese children and adolescents tend to persist throughout adulthood if not treated, thus contributing to an ever earlier establishment of CVD. Therefore, the high percentage of clinical and metabolic changes of cardiovascular risk found in the present study on overweight and obese children and adolescents indicates the need to develop local public health policies and to establish measures involving changes in the habits and lifestyle of this population.</p></sec><sec><title>AUTHOR CONTRIBUTIONS</title><p>Palhares HM developed this research and wrote the manuscript. Silva AP, Resende DC and Palhares HM performed nutritional evaluation of children and adolescents studied. Pereira GA e Palhares HM performed the statistical analysis and configured the tables. Rodrigues-J&#x000fa;nior V guided the assays of this research. Borges MF planned and guided this research.</p></sec><sec><title>ACKNOWLEDGMENTS</title><p>We thank Prof. Dr. Vinicius Nahime de Brito of the Hormone Laboratory and Molecular Genetics (LIM 42) of the Hospital and the Faculty of Medicine of the University of S&#x000e3;o Paulo-SP for determining the leptin levels.</p></sec></body><back><fn-group><fn fn-type="COI-statement"><p>No potential conflict of interest was reported.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="b1-cln_72p36"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Eyzaguirre</surname><given-names>F</given-names></name><name><surname>Mericq</surname><given-names>V</given-names></name></person-group>
<article-title>Insulin resistance markers in children</article-title>
<source>Horm Res</source>
<year>2009</year>
<volume>71</volume>
<issue>(2)</issue>
<fpage>65</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="doi">10.1159/000183894</pub-id><pub-id pub-id-type="pmid">19129710</pub-id></element-citation></ref><ref id="b2-cln_72p36"><element-citation publication-type="webpage">
<person-group person-group-type="author"><collab>World Obesity Organization</collab></person-group>
<source>World Map of Obesity. Obesity prevalence worldwide &#x02013; Girls, Boys</source>
<comment>Available at</comment>
<comment><ext-link ext-link-type="uri" xlink:href="http://www.worldobesity.org/resources/world-map-obesity/">http://www.worldobesity.org/resources/world-map-obesity/</ext-link>&#x0003e;. Accessed on September 13, 2016</comment></element-citation></ref><ref id="b3-cln_72p36"><element-citation publication-type="book">
<person-group person-group-type="author"><collab>Brasil. Minist&#x000e9;rio da Sa&#x000fa;de; Instituto Brasileiro de Geografia e Estat&#x000ed;stica &#x02013; IBGE; Minist&#x000e9;rio do Planejamento, Or&#x000e7;amento e Gest&#x000e3;o. Pesquisa de Or&#x000e7;amentos Familiares (POF) 2008-2009</collab></person-group>
<source>Antropometria e estado nutricional de crian&#x000e7;as, adolescentes e adultos no Brasil</source>
<publisher-loc>Rio de Janeiro</publisher-loc>
<publisher-name>IBGE</publisher-name>
<year>2010</year>
</element-citation></ref><ref id="b4-cln_72p36"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>DAdamo</surname><given-names>E</given-names></name><name><surname>Santoro</surname><given-names>N</given-names></name><name><surname>Caprio</surname><given-names>S</given-names></name></person-group>
<article-title>Metabolic syndrome in pediatrics: old concepts revised, new concepts discussed</article-title>
<source>Curr Probl Pediatr Adolesc Health Care</source>
<year>2013</year>
<volume>43</volume>
<issue>(5)</issue>
<fpage>114</fpage>
<lpage>23</lpage>
<pub-id pub-id-type="doi">10.1016/j.cppeds.2013.02.004</pub-id><pub-id pub-id-type="pmid">23582593</pub-id></element-citation></ref><ref id="b5-cln_72p36"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Morrison</surname><given-names>JA</given-names></name><name><surname>Glueck</surname><given-names>CJ</given-names></name><name><surname>Woo</surname><given-names>JG</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name></person-group>
<article-title>Risk factors for cardiovascular disease and type 2 diabetes retained from childhood to adulthood predict adult outcomes: the Princeton LRC follow-up study</article-title>
<source>Int J Pediatr Endocrinol</source>
<year>2012</year>
<volume>2012</volume>
<issue>(1)</issue>
<fpage>6</fpage>
<pub-id pub-id-type="doi">10.1186/1687-9856-2012-6</pub-id><pub-id pub-id-type="pmid">22507454</pub-id></element-citation></ref><ref id="b6-cln_72p36"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Romualdo</surname><given-names>MC</given-names></name><name><surname>N&#x000f3;brega</surname><given-names>FJ</given-names></name><name><surname>Escriv&#x000e3;o</surname><given-names>MA</given-names></name></person-group>
<article-title>Insulin resistance in obese children and adolescents</article-title>
<source>J Pediatr (Rio J)</source>
<year>2014</year>
<volume>90</volume>
<issue>(6)</issue>
<fpage>600</fpage>
<lpage>7</lpage><pub-id pub-id-type="pmid">25019650</pub-id></element-citation></ref><ref id="b7-cln_72p36"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Arslan</surname><given-names>N</given-names></name><name><surname>Erdur</surname><given-names>B</given-names></name><name><surname>Aydin</surname><given-names>A</given-names></name></person-group>
<article-title>Hormones and cytokines in childhood obesity</article-title>
<source>Indian Pediatr</source>
<year>2010</year>
<volume>47</volume>
<issue>(10)</issue>
<fpage>829</fpage>
<lpage>39</lpage>
<pub-id pub-id-type="doi">10.1007/s13312-010-0142-y</pub-id><pub-id pub-id-type="pmid">21048235</pub-id></element-citation></ref><ref id="b8-cln_72p36"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pires</surname><given-names>A</given-names></name><name><surname>Martins</surname><given-names>P</given-names></name><name><surname>Pereira</surname><given-names>AM</given-names></name><name><surname>Marinho</surname><given-names>J</given-names></name><name><surname>Vaz Silva</surname><given-names>P</given-names></name><name><surname>Marques</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Pro-inflammatory triggers in childhood obesity: correlation between leptin, adiponectin and high-sensitivity C-reactive protein in a group of obese Portuguese children</article-title>
<source>Rev Port Cardiol</source>
<year>2014</year>
<volume>33</volume>
<issue>(11)</issue>
<fpage>691</fpage>
<lpage>7</lpage><pub-id pub-id-type="pmid">25448795</pub-id></element-citation></ref><ref id="b9-cln_72p36"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Madeira</surname><given-names>IR</given-names></name><name><surname>Carvalho</surname><given-names>CN</given-names></name><name><surname>Gazolla</surname><given-names>FM</given-names></name><name><surname>Pinto</surname><given-names>LW</given-names></name><name><surname>Borges</surname><given-names>MA</given-names></name><name><surname>Bordallo</surname><given-names>MA</given-names></name></person-group>
<article-title>Impact of obesity on metabolic syndrome components and adipokines in prepubertal children</article-title>
<source>J Pediatr (Rio J)</source>
<year>2009</year>
<volume>85</volume>
<issue>(3)</issue>
<fpage>261</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1590/S0021-75572009000300013</pub-id><pub-id pub-id-type="pmid">19212612</pub-id></element-citation></ref><ref id="b10-cln_72p36"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Masquio</surname><given-names>DC</given-names></name><name><surname>Ganen Ade</surname><given-names>P</given-names></name><name><surname>Campos</surname><given-names>RM</given-names></name><name><surname>Sanches Pde</surname><given-names>L</given-names></name><name><surname>Corgosinho</surname><given-names>FC</given-names></name><name><surname>Caranti</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>Cut-off values of waist circumference to predict metabolic syndrome in obese adolescents</article-title>
<source>Nutr Hosp</source>
<year>2015</year>
<volume>31</volume>
<issue>(4)</issue>
<fpage>1540</fpage>
<lpage>50</lpage>
<pub-id pub-id-type="doi">10.3305/nh.2015.31.4.8442</pub-id><pub-id pub-id-type="pmid">25795939</pub-id></element-citation></ref><ref id="b11-cln_72p36"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mastroeni</surname><given-names>SS</given-names></name><name><surname>Mastroeni</surname><given-names>MF</given-names></name><name><surname>Gon&#x000e7;alves Mde</surname><given-names>C</given-names></name><name><surname>Debortoli</surname><given-names>G</given-names></name><name><surname>da Silva</surname><given-names>NN</given-names></name><name><surname>Bernal</surname><given-names>RT</given-names></name><etal/></person-group>
<article-title>Cardiometabolic risk markers of normal weight and excess body weight in Brazilian adolescents</article-title>
<source>Appl Physiol Nutr Metab</source>
<year>2016</year>
<volume>41</volume>
<issue>(6)</issue>
<fpage>659</fpage>
<lpage>65</lpage>
<pub-id pub-id-type="doi">10.1139/apnm-2015-0632</pub-id><pub-id pub-id-type="pmid">27227571</pub-id></element-citation></ref><ref id="b12-cln_72p36"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Silva</surname><given-names>AP</given-names></name><name><surname>Feilbelmann</surname><given-names>TC</given-names></name><name><surname>Silva</surname><given-names>DC</given-names></name><name><surname>Palhares</surname><given-names>HM</given-names></name><name><surname>Scatena</surname><given-names>LM</given-names></name><name><surname>Borges</surname><given-names>MF</given-names></name></person-group>
<article-title>Prevalence of overweight and obesity in children and adolescentes at public and private schools from Uberaba-Brazil</article-title>
<source>Horm Res Paediatr</source>
<year>2014</year>
<volume>82</volume>
<issue>(suppl1)</issue>
<fpage>393</fpage></element-citation></ref><ref id="b13-cln_72p36"><element-citation publication-type="webpage">
<person-group person-group-type="author"><collab>World Health Organization (WHO)</collab></person-group>
<source>The WHO Child Growth Standarts</source>
<comment>Available at</comment>
<comment><ext-link ext-link-type="uri" xlink:href="http://www.who.int/childgrowth/en/">http://www.who.int/childgrowth/en/</ext-link></comment>
<comment>Accessed on June 10, 2016</comment></element-citation></ref><ref id="b14-cln_72p36"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Slaughter</surname><given-names>MH</given-names></name><name><surname>Lohman</surname><given-names>TG</given-names></name><name><surname>Boileau</surname><given-names>RA</given-names></name><name><surname>Horswill</surname><given-names>CA</given-names></name><name><surname>Stillman</surname><given-names>RJ</given-names></name><name><surname>Van Loan</surname><given-names>MD</given-names></name><etal/></person-group>
<article-title>Skinfold equations for estimation of body fatness in children and youth</article-title>
<source>Hum Biol</source>
<year>1988</year>
<volume>60</volume>
<issue>(5)</issue>
<fpage>709</fpage>
<lpage>23</lpage><pub-id pub-id-type="pmid">3224965</pub-id></element-citation></ref><ref id="b15-cln_72p36"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Freedman</surname><given-names>DS</given-names></name><name><surname>Serdula</surname><given-names>MK</given-names></name><name><surname>Srinivasan</surname><given-names>SR</given-names></name><name><surname>Berenson</surname><given-names>GS</given-names></name></person-group>
<article-title>Relation of circumferences and skinfold thicknesses to lipid and insulin concentrations in children and adolescents: the Bogalusa Heart Study</article-title>
<source>Am J Clin Nutr</source>
<year>1999</year>
<volume>69</volume>
<issue>(2)</issue>
<fpage>308</fpage>
<lpage>17</lpage><pub-id pub-id-type="pmid">9989697</pub-id></element-citation></ref><ref id="b16-cln_72p36"><element-citation publication-type="journal">
<person-group person-group-type="author"><collab>Sociedade Brasileira de Cardiologia</collab></person-group>
<article-title>I Diretriz de Preven&#x000e7;&#x000e3;o da Aterosclerose na Inf&#x000e2;ncia e na Adolesc&#x000ea;ncia</article-title>
<source>Arq Bras Cardiol</source>
<year>2005</year>
<volume>85</volume>
<issue>(Supl 6)</issue>
<fpage>1</fpage>
<lpage>36</lpage>
</element-citation></ref><ref id="b17-cln_72p36"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marshall</surname><given-names>WA</given-names></name><name><surname>Tanner</surname><given-names>JM</given-names></name></person-group>
<article-title>Variations in pattern of pubertal changes in girls</article-title>
<source>Arch Dis Child</source>
<year>1969</year>
<volume>44</volume>
<issue>(235)</issue>
<fpage>291</fpage>
<lpage>303</lpage>
<pub-id pub-id-type="doi">10.1136/adc.44.235.291</pub-id><pub-id pub-id-type="pmid">5785179</pub-id></element-citation></ref><ref id="b18-cln_72p36"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marshall</surname><given-names>WA</given-names></name><name><surname>Tanner</surname><given-names>JM</given-names></name></person-group>
<article-title>Variations in pattern of pubertal changes in boys</article-title>
<source>Arch Dis Child</source>
<year>1970</year>
<volume>45</volume>
<issue>(239)</issue>
<fpage>13</fpage>
<lpage>23</lpage>
<pub-id pub-id-type="doi">10.1136/adc.45.239.13</pub-id><pub-id pub-id-type="pmid">5440182</pub-id></element-citation></ref><ref id="b19-cln_72p36"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Friedewald</surname><given-names>WT</given-names></name><name><surname>Levy</surname><given-names>RI</given-names></name><name><surname>Fredrickson</surname><given-names>DS</given-names></name></person-group>
<article-title>Estimation of the concentration of low-density lipoprotein cholesterol, in plasma, without use of the preparative ultracentrifuge</article-title>
<source>Clin Chem</source>
<year>1972</year>
<volume>18</volume>
<issue>(6)</issue>
<fpage>499</fpage>
<lpage>502</lpage><pub-id pub-id-type="pmid">4337382</pub-id></element-citation></ref><ref id="b20-cln_72p36"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Madeira</surname><given-names>IR</given-names></name><name><surname>Carvalho</surname><given-names>CN</given-names></name><name><surname>Gazolla</surname><given-names>FM</given-names></name><name><surname>Matos</surname><given-names>HJ</given-names></name><name><surname>Borges</surname><given-names>MA</given-names></name><name><surname>Bordallo</surname><given-names>MA</given-names></name></person-group>
<article-title>Ponto de corte do &#x00026;iacute;ndice &#x0003c;italic&#x0003e;Homeostatic Model Assessment for Insulin Resistance&#x0003c;/italic&#x0003e; (HOMA-IR) avaliado pela curva &#x0003c;italic&#x0003e;Receiver Operating Characteristic&#x0003c;/italic&#x0003e; (ROC) na detec&#x00026;ccedil;&#x00026;atilde;o de s&#x00026;iacute;ndrome metab&#x00026;oacute;lica em crian&#x00026;ccedil;as pr&#x00026;eacute;- p&#x00026;uacute;beres com excesso de peso</article-title>
<source>Arq Bras Endocrinol Metabol</source>
<year>2008</year>
<volume>52</volume>
<issue>(9)</issue>
<fpage>1466</fpage>
<lpage>73</lpage>
<pub-id pub-id-type="doi">10.1590/S0004-27302008000900010</pub-id><pub-id pub-id-type="pmid">19197455</pub-id></element-citation></ref><ref id="b21-cln_72p36"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Garc&#x000ed;a Cuartero</surname><given-names>B</given-names></name><name><surname>Garc&#x000ed;a Lacalle</surname><given-names>C</given-names></name><name><surname>Jim&#x000e9;nez Lobo</surname><given-names>C</given-names></name><name><surname>Gonz&#x000e1;lez Vergaz</surname><given-names>A</given-names></name><name><surname>Calvo Rey</surname><given-names>C</given-names></name><name><surname>Alc&#x000e1;zar Villar</surname><given-names>MJ</given-names></name><etal/></person-group>
<article-title>The HOMA and QUICKI indexes, and insulin and C-peptide levels in healthy children. Cut off points to identify metabolic syndrome in healthy children</article-title>
<source>An Pediatr (Barc)</source>
<year>2007</year>
<volume>66</volume>
<issue>(5)</issue>
<fpage>481</fpage>
<lpage>90</lpage>
<pub-id pub-id-type="doi">10.1157/13102513</pub-id><pub-id pub-id-type="pmid">17517203</pub-id></element-citation></ref><ref id="b22-cln_72p36"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zimmet</surname><given-names>P</given-names></name><name><surname>Alberti</surname><given-names>KG</given-names></name><name><surname>Kaufman</surname><given-names>F</given-names></name><name><surname>Tajima</surname><given-names>N</given-names></name><name><surname>Silink</surname><given-names>M</given-names></name><name><surname>Arslanian</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>The metabolic syndrome in children and adolescents &#x00026;ndash; an IDF consensus report</article-title>
<source>Pediatr Diabetes</source>
<year>2007</year>
<volume>8</volume>
<issue>(5)</issue>
<fpage>299</fpage>
<lpage>306</lpage>
<pub-id pub-id-type="doi">10.1111/j.1399-5448.2007.00271.x</pub-id><pub-id pub-id-type="pmid">17850473</pub-id></element-citation></ref><ref id="b23-cln_72p36"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Quadros</surname><given-names>FF</given-names></name><name><surname>Gutierrez</surname><given-names>LL</given-names></name><name><surname>Ribeiro</surname><given-names>JL</given-names></name></person-group>
<article-title>Obesidade e fatores de risco cardiovascular em filhos de obesos: uma revis&#x00026;atilde;o</article-title>
<source>Sci Med</source>
<year>2013</year>
<volume>23</volume>
<issue>(2)</issue>
<fpage>119</fpage>
<lpage>26</lpage></element-citation></ref><ref id="b24-cln_72p36"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fonseca</surname><given-names>FL</given-names></name><name><surname>Brand&#x000e3;o</surname><given-names>AA</given-names></name><name><surname>Pozzan</surname><given-names>R</given-names></name><name><surname>Campana</surname><given-names>EM</given-names></name><name><surname>Pizzi</surname><given-names>OL</given-names></name><name><surname>Magalh&#x000e3;es</surname><given-names>ME</given-names></name><etal/></person-group>
<article-title>Overweight and cardiovascular risk among young adults followed-up for 17 years: the Rio de Janeiro study, Brazil</article-title>
<source>Arq Bras Cardiol</source>
<year>2010</year>
<volume>94</volume>
<issue>(2)</issue>
<fpage>193</fpage>
<lpage>201</lpage>
<pub-id pub-id-type="doi">10.1590/S0066-782X2010000200011</pub-id><pub-id pub-id-type="pmid">20428615</pub-id></element-citation></ref><ref id="b25-cln_72p36"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mokha</surname><given-names>JS</given-names></name><name><surname>Srinivasan</surname><given-names>SR</given-names></name><name><surname>Dasmahapatra</surname><given-names>P</given-names></name><name><surname>Fernandez</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Utility of waist-to-height ratio in assessing the status of central obesity and related cardiometabolic risk profile among normal weight and overweight/obese children: the Bogalusa Heart Study</article-title>
<source>BMC Pediatr</source>
<year>2010</year>
<volume>10</volume><fpage>73</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2431-10-73</pub-id><pub-id pub-id-type="pmid">20937123</pub-id></element-citation></ref><ref id="b26-cln_72p36"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Moser</surname><given-names>DC</given-names></name><name><surname>Giuliano Ide</surname><given-names>C</given-names></name><name><surname>Titski</surname><given-names>AC</given-names></name><name><surname>Gaya</surname><given-names>AR</given-names></name><name><surname>Coelho-e-Silva</surname><given-names>MJ</given-names></name><name><surname>Leite</surname><given-names>N</given-names></name></person-group>
<article-title>Anthropometric measures and blood pressure in school children</article-title>
<source>J Pediatr (Rio J)</source>
<year>2013</year>
<volume>89</volume>
<issue>(3)</issue>
<fpage>243</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1016/j.jped.2012.11.006</pub-id><pub-id pub-id-type="pmid">23684458</pub-id></element-citation></ref><ref id="b27-cln_72p36"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pizzi</surname><given-names>J</given-names></name><name><surname>Silva</surname><given-names>LR</given-names></name><name><surname>Moser</surname><given-names>D</given-names></name><name><surname>Leite</surname><given-names>N</given-names></name></person-group>
<article-title>Rela&#x00026;ccedil;&#x00026;atilde;o entre aterosclerose subcl&#x00026;iacute;nica, press&#x00026;atilde;o arterial e perfil lip&#x00026;iacute;dico em crian&#x00026;ccedil;as e adolescentes obesos: uma revis&#x00026;atilde;o sistem&#x00026;aacute;tica</article-title>
<source>Arq Bras Endocrinol Metabol</source>
<year>2013</year>
<volume>57</volume>
<issue>(1)</issue>
<fpage>1</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1590/S0004-27302013000100001</pub-id><pub-id pub-id-type="pmid">23440093</pub-id></element-citation></ref><ref id="b28-cln_72p36"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Slyper</surname><given-names>AH</given-names></name><name><surname>Rosenberg</surname><given-names>H</given-names></name><name><surname>Kabra</surname><given-names>A</given-names></name><name><surname>Weiss</surname><given-names>MJ</given-names></name><name><surname>Blech</surname><given-names>B</given-names></name><name><surname>Gensler</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Early atherogenesis and visceral fat in obese adolescents</article-title>
<source>Int J Obes (Lond)</source>
<year>2014</year>
<volume>38</volume>
<issue>(7)</issue>
<fpage>954</fpage>
<lpage>8</lpage><pub-id pub-id-type="pmid">24451186</pub-id></element-citation></ref><ref id="b29-cln_72p36"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Juonala</surname><given-names>M</given-names></name><name><surname>Magnussen</surname><given-names>CG</given-names></name><name><surname>Berenson</surname><given-names>GS</given-names></name><name><surname>Venn</surname><given-names>A</given-names></name><name><surname>Burns</surname><given-names>TL</given-names></name><name><surname>Sabin</surname><given-names>MA</given-names></name><etal/></person-group>
<article-title>Childhood Adiposity, Adult Adiposity, and Cardiovascular Risk Factors</article-title>
<source>N Engl J Med</source>
<year>2011</year>
<volume>365</volume>
<issue>(20)</issue>
<fpage>1876</fpage>
<lpage>85</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMoa1010112</pub-id><pub-id pub-id-type="pmid">22087679</pub-id></element-citation></ref><ref id="b30-cln_72p36"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bao</surname><given-names>W</given-names></name><name><surname>Srinivasan</surname><given-names>S</given-names></name><name><surname>Berenson</surname><given-names>G</given-names></name></person-group>
<article-title>Persistent elevation of plasma insulin levels is associated with increased cardiovascular risk in children and young adults. The Bogalusa Heart Study</article-title>
<source>Circulation</source>
<year>1996</year>
<volume>93</volume>
<issue>(1)</issue>
<fpage>54</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1161/01.CIR.93.1.54</pub-id><pub-id pub-id-type="pmid">8616941</pub-id></element-citation></ref><ref id="b31-cln_72p36"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Morrison</surname><given-names>JA</given-names></name><name><surname>Glueck</surname><given-names>CJ</given-names></name><name><surname>Umar</surname><given-names>M</given-names></name><name><surname>Daniels</surname><given-names>S</given-names></name><name><surname>Dolan</surname><given-names>LM</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name></person-group>
<article-title>Hyperinsulinemia and metabolic syndrome at mean age of 10 years in black and white schoolgirls and development of impaired fasting glucose and type 2 diabetes mellitus by mean age of 24 years</article-title>
<source>Metabolism</source>
<year>2011</year>
<volume>60</volume>
<issue>(1)</issue>
<fpage>24</fpage>
<lpage>31</lpage>
<pub-id pub-id-type="doi">10.1016/j.metabol.2009.12.013</pub-id><pub-id pub-id-type="pmid">20096893</pub-id></element-citation></ref><ref id="b32-cln_72p36"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Morrison</surname><given-names>JA</given-names></name><name><surname>Friedman</surname><given-names>LA</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>Glueck</surname><given-names>CJ</given-names></name></person-group>
<article-title>Metabolic syndrome in childhood predicts adult metabolic syndrome and type 2 diabetes mellitus 25 to 30 years later</article-title>
<source>J Pediatr</source>
<year>2008</year>
<volume>152</volume>
<issue>(2)</issue>
<fpage>201</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1016/j.jpeds.2007.09.010</pub-id><pub-id pub-id-type="pmid">18206689</pub-id></element-citation></ref><ref id="b33-cln_72p36"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mieldazis</surname><given-names>SF</given-names></name><name><surname>Azzalis</surname><given-names>LA</given-names></name><name><surname>Junqueira</surname><given-names>VB</given-names></name><name><surname>Souza</surname><given-names>FI</given-names></name><name><surname>Sarni</surname><given-names>RO</given-names></name><name><surname>Fonseca</surname><given-names>FL</given-names></name></person-group>
<article-title>Hyperinsulinism assessment in a sample of prepubescent children</article-title>
<source>J Pediatr (Rio J)</source>
<year>2010</year>
<volume>86</volume>
<issue>(3)</issue>
<fpage>245</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1590/S0021-75572010000300014</pub-id><pub-id pub-id-type="pmid">20520923</pub-id></element-citation></ref><ref id="b34-cln_72p36"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Leon-Cabrera</surname><given-names>S</given-names></name><name><surname>Sol&#x000ed;s-Lozano</surname><given-names>L</given-names></name><name><surname>Su&#x000e1;rez-&#x000c1;lvarez</surname><given-names>K</given-names></name><name><surname>Gonz&#x000e1;lez-Ch&#x000e1;vez</surname><given-names>A</given-names></name><name><surname>B&#x000e9;jar</surname><given-names>YL</given-names></name><name><surname>Robles-D&#x000ed;az</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Hyperleptinemia is associated with parameters of low-grade systemic inflammation and metabolic dysfunction in obese human beings</article-title>
<source>Front Integr Neurosci</source>
<year>2013</year>
<volume>7</volume>
<fpage>62</fpage><pub-id pub-id-type="pmid">23986664</pub-id></element-citation></ref><ref id="b35-cln_72p36"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Valle</surname><given-names>M</given-names></name><name><surname>Martos</surname><given-names>R</given-names></name><name><surname>Gasc&#x000f3;n</surname><given-names>F</given-names></name><name><surname>Ca&#x000f1;ete</surname><given-names>R</given-names></name><name><surname>Zafra</surname><given-names>MA</given-names></name><name><surname>Morales</surname><given-names>R</given-names></name></person-group>
<article-title>Low &#x00026;ndash; grade systemic inflammation, hypoadiponectinemia and a high concentration of leptin are present in very young obese children, and correlate with metabolic syndrome</article-title>
<source>Diabetes Metab</source>
<year>2005</year>
<volume>31</volume>
<issue>(1)</issue>
<fpage>55</fpage>
<lpage>62</lpage>
<pub-id pub-id-type="doi">10.1016/S1262-3636(07)70167-2</pub-id><pub-id pub-id-type="pmid">15803114</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap id="t1-cln_72p36" position="float"><label>Table 1</label><caption><p>Clinical and laboratory characterization of overweight and obese children and adolescents recruited from the public schools of the Municipality of Uberaba, Minas Gerais State, Brazil, from February 2013 to July 2014.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="left" colspan="1">Variables</th><th colspan="2" align="center" rowspan="1">Group</th><th rowspan="2" align="center" colspan="1"><italic>p</italic>-value</th></tr><tr><th align="center" rowspan="1" colspan="1">Overweight (n=65)</th><th align="center" rowspan="1" colspan="1">Obese (n=96)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (years) <xref ref-type="table-fn" rid="tfn2-cln_72p36">#</xref></td><td align="center" rowspan="1" colspan="1">12.6&#x000b1;3.4</td><td align="center" rowspan="1" colspan="1">10.9&#x000b1;2.5</td><td align="center" rowspan="1" colspan="1">0.0002</td></tr><tr><td align="left" rowspan="1" colspan="1">Sex (M/F) <xref ref-type="table-fn" rid="tfn3-cln_72p36">&#x003d5;</xref></td><td align="center" rowspan="1" colspan="1">19/46</td><td align="center" rowspan="1" colspan="1">39/57</td><td align="center" rowspan="1" colspan="1">0.13</td></tr><tr><td align="left" rowspan="1" colspan="1">Pubertal stage (pre-pubertal/pubertal) <xref ref-type="table-fn" rid="tfn3-cln_72p36">&#x003d5;</xref></td><td align="center" rowspan="1" colspan="1">17/48</td><td align="center" rowspan="1" colspan="1">47/49</td><td align="center" rowspan="1" colspan="1">0.003</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>) <xref ref-type="table-fn" rid="tfn2-cln_72p36">#</xref></td><td align="center" rowspan="1" colspan="1">23.0&#x000b1;3.1</td><td align="center" rowspan="1" colspan="1">27.1&#x000b1;3.7</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI z-score <xref ref-type="table-fn" rid="tfn4-cln_72p36">&#x000a4;</xref></td><td align="center" rowspan="1" colspan="1">1.6 (1.0-2.0)</td><td align="center" rowspan="1" colspan="1">2.57 (2.0-4.9)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">Waist circumference (cm) <xref ref-type="table-fn" rid="tfn2-cln_72p36">#</xref></td><td align="center" rowspan="1" colspan="1">73.4&#x000b1;8.4</td><td align="center" rowspan="1" colspan="1">84.0&#x000b1;10.7</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">Body fat percentage <xref ref-type="table-fn" rid="tfn2-cln_72p36">#</xref></td><td align="center" rowspan="1" colspan="1">34.5&#x000b1;9.0</td><td align="center" rowspan="1" colspan="1">43.1&#x000b1;8.4</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">Systolic blood pressure (mmHg) <xref ref-type="table-fn" rid="tfn2-cln_72p36">#</xref></td><td align="center" rowspan="1" colspan="1">106.4&#x000b1;9.7</td><td align="center" rowspan="1" colspan="1">108.7&#x000b1;10.0</td><td align="center" rowspan="1" colspan="1">0.15</td></tr><tr><td align="left" rowspan="1" colspan="1">Diastolic blood pressure (mmHg) <xref ref-type="table-fn" rid="tfn2-cln_72p36">#</xref></td><td align="center" rowspan="1" colspan="1">68.6&#x000b1;7.6</td><td align="center" rowspan="1" colspan="1">70.3&#x000b1;7.9</td><td align="center" rowspan="1" colspan="1">0.19</td></tr><tr><td align="left" rowspan="1" colspan="1">Total cholesterol (mg/dL) <xref ref-type="table-fn" rid="tfn2-cln_72p36">#</xref></td><td align="center" rowspan="1" colspan="1">159.0&#x000b1;33.5</td><td align="center" rowspan="1" colspan="1">169.9&#x000b1;32.5</td><td align="center" rowspan="1" colspan="1">0.04</td></tr><tr><td align="left" rowspan="1" colspan="1">HDL-cholesterol (mg/dL) <xref ref-type="table-fn" rid="tfn2-cln_72p36">#</xref></td><td align="center" rowspan="1" colspan="1">46.7&#x000b1;10.8</td><td align="center" rowspan="1" colspan="1">44.6&#x000b1;11.2</td><td align="center" rowspan="1" colspan="1">0.23</td></tr><tr><td align="left" rowspan="1" colspan="1">LDL-cholesterol (mg/dL) <xref ref-type="table-fn" rid="tfn2-cln_72p36">#</xref></td><td align="center" rowspan="1" colspan="1">94.6&#x000b1;29.6</td><td align="center" rowspan="1" colspan="1">105.5&#x000b1;30.3</td><td align="center" rowspan="1" colspan="1">0.03</td></tr><tr><td align="left" rowspan="1" colspan="1">Triglycerides (mg/dL) <xref ref-type="table-fn" rid="tfn4-cln_72p36">&#x000a4;</xref></td><td align="center" rowspan="1" colspan="1">81.0 (38.0-196.0)</td><td align="center" rowspan="1" colspan="1">91.0 (31.0-445.0)</td><td align="center" rowspan="1" colspan="1">0.04</td></tr><tr><td align="left" rowspan="1" colspan="1">TG/HDL<xref ref-type="table-fn" rid="tfn4-cln_72p36">&#x000a4;</xref></td><td align="center" rowspan="1" colspan="1">1.76 (0.6-5.8)</td><td align="center" rowspan="1" colspan="1">2.1 (0.6-10.3)</td><td align="center" rowspan="1" colspan="1">0.04</td></tr><tr><td align="left" rowspan="1" colspan="1">Glucose (mg/dL) <xref ref-type="table-fn" rid="tfn2-cln_72p36">#</xref></td><td align="center" rowspan="1" colspan="1">85.4&#x000b1;12.1</td><td align="center" rowspan="1" colspan="1">87.6&#x000b1;11.5</td><td align="center" rowspan="1" colspan="1">0.230</td></tr><tr><td align="left" rowspan="1" colspan="1">Insulin (&#x000b5;IU/mL) <xref ref-type="table-fn" rid="tfn4-cln_72p36">&#x000a4;</xref></td><td align="center" rowspan="1" colspan="1">11.6 (3.5-32.8)</td><td align="center" rowspan="1" colspan="1">14.5 (1.4-117.2)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">HOMA-IR <xref ref-type="table-fn" rid="tfn4-cln_72p36">&#x000a4;</xref></td><td align="center" rowspan="1" colspan="1">2.3 (0.7-7.1)</td><td align="center" rowspan="1" colspan="1">3.2 (0.3-28.7)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">Leptin (ng/mL) <xref ref-type="table-fn" rid="tfn2-cln_72p36">#</xref></td><td align="center" rowspan="1" colspan="1">15.2&#x000b1;9.4</td><td align="center" rowspan="1" colspan="1">24.1&#x000b1;11.4</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">Adiponectin (ng/mL) <xref ref-type="table-fn" rid="tfn4-cln_72p36">&#x000a4;</xref></td><td align="center" rowspan="1" colspan="1">6.5 (0.0-96.0)</td><td align="center" rowspan="1" colspan="1">6.5 (0.0-43.2)</td><td align="center" rowspan="1" colspan="1">0.8</td></tr></tbody></table><table-wrap-foot><fn id="tfn1-cln_72p36"><p>Source: the author</p></fn><fn id="tfn2-cln_72p36"><label>#</label><p><italic>t</italic>-test, values are expressed as the means &#x000b1; standard deviation;</p></fn><fn id="tfn3-cln_72p36"><label>&#x003d5;</label><p>Chi-squared test;</p></fn><fn id="tfn4-cln_72p36"><label>&#x000a4;</label><p>Mann-Whitney test, values are expressed as medians (Vmin-Vmax).</p></fn></table-wrap-foot></table-wrap><table-wrap id="t2-cln_72p36" position="float"><label>Table 2</label><caption><p>Percentage of clinical changes in overweight and obese children and adolescents recruited from the public schools of the Municipality of Uberaba, Minas Gerais State, Brazil, from February 2013 to July 2014.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" valign="middle" align="left" colspan="1">Changes</th><th valign="middle" colspan="3" align="center" rowspan="1">Group (%)</th><th valign="middle" align="left" rowspan="2" colspan="1"><italic>p</italic>-value</th><th valign="middle" align="left" rowspan="2" colspan="1">OR (95% CI)</th></tr><tr><th valign="middle" align="center" rowspan="1" colspan="1">General (n=161)</th><th valign="middle" align="center" rowspan="1" colspan="1">Overweight (n=65)</th><th valign="middle" align="center" rowspan="1" colspan="1">Obese (n=96)</th></tr></thead><tbody><tr><td valign="middle" align="left" rowspan="1" colspan="1">Waist circumference <xref ref-type="table-fn" rid="tfn6-cln_72p36">&#x000a7;</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">45.3</td><td valign="middle" align="center" rowspan="1" colspan="1">17.0</td><td valign="middle" align="center" rowspan="1" colspan="1">64.6</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td><td valign="middle" align="center" rowspan="1" colspan="1">9.0 (4.1-19.4)</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Systolic blood pressure <xref ref-type="table-fn" rid="tfn6-cln_72p36">&#x000a7;</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">8.1</td><td valign="middle" align="center" rowspan="1" colspan="1">3.1</td><td valign="middle" align="center" rowspan="1" colspan="1">11.4</td><td valign="middle" align="center" rowspan="1" colspan="1">0.05</td><td valign="middle" align="center" rowspan="1" colspan="1">4.1 (0.9-19.0)</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Diastolic blood pressure <xref ref-type="table-fn" rid="tfn6-cln_72p36">&#x000a7;</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">9.3</td><td valign="middle" align="center" rowspan="1" colspan="1">6.1</td><td valign="middle" align="center" rowspan="1" colspan="1">11.4</td><td valign="middle" align="center" rowspan="1" colspan="1">0.25</td><td valign="middle" align="center" rowspan="1" colspan="1">1.9 (0.6-6.5)</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Acanthosis nigricans <xref ref-type="table-fn" rid="tfn7-cln_72p36">&#x02020;</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">51.6</td><td valign="middle" align="center" rowspan="1" colspan="1">32.3</td><td valign="middle" align="center" rowspan="1" colspan="1">64.6</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td><td valign="middle" align="center" rowspan="1" colspan="1">3.8 (2.0-7.4)</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Cervical acanthosis nigricans <xref ref-type="table-fn" rid="tfn7-cln_72p36">&#x02020;</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">44.1</td><td valign="middle" align="center" rowspan="1" colspan="1">18.5</td><td valign="middle" align="center" rowspan="1" colspan="1">61.5</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td><td valign="middle" align="center" rowspan="1" colspan="1">7.0 (3.3-14.9)</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Axillary acanthosis nigricans <xref ref-type="table-fn" rid="tfn7-cln_72p36">&#x02020;</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">36.6</td><td valign="middle" align="center" rowspan="1" colspan="1">21.5</td><td valign="middle" align="center" rowspan="1" colspan="1">46.9</td><td valign="middle" align="center" rowspan="1" colspan="1">0.001</td><td valign="middle" align="center" rowspan="1" colspan="1">3.2 (1.6-6.6)</td></tr></tbody></table><table-wrap-foot><fn id="tfn5-cln_72p36"><p>Source: the author</p></fn><fn id="tfn6-cln_72p36"><label>&#x000a7;</label><p>Increased;</p></fn><fn id="tfn7-cln_72p36"><label>&#x02020;</label><p>Present;</p></fn><fn id="tfn8-cln_72p36"><p>OR: odds ratio; 95% CI: 95% confidence interval.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t3-cln_72p36" position="float"><label>Table 3</label><caption><p>Percentage of laboratory changes in overweight and obese children and adolescents recruited from the public schools of the Municipality of Uberaba, Minas Gerais State, Brazil, from February 2013 to July 2014.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" valign="middle" align="left" colspan="1">Changes</th><th valign="middle" colspan="3" align="center" rowspan="1">Group (%)</th><th valign="middle" align="left" rowspan="2" colspan="1"><italic>p</italic>-value</th><th valign="middle" align="left" rowspan="2" colspan="1">OR (95% CI)</th></tr><tr><th valign="middle" align="center" rowspan="1" colspan="1">General (n=161)</th><th valign="middle" align="center" rowspan="1" colspan="1">Overweight (n=65)</th><th valign="middle" align="center" rowspan="1" colspan="1">Obese (n=96)</th></tr></thead><tbody><tr><td valign="middle" align="left" rowspan="1" colspan="1">Total cholesterol <xref ref-type="table-fn" rid="tfn10-cln_72p36">&#x000a7;</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">40.4</td><td valign="middle" align="center" rowspan="1" colspan="1">32.3</td><td valign="middle" align="center" rowspan="1" colspan="1">45.8</td><td valign="middle" align="center" rowspan="1" colspan="1">0.08</td><td valign="middle" align="center" rowspan="1" colspan="1">1.8 (0.9-3.4)</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">HDL-cholesterol <xref ref-type="table-fn" rid="tfn11-cln_72p36">&#x003d5;</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">47.2</td><td valign="middle" align="center" rowspan="1" colspan="1">39.7</td><td valign="middle" align="center" rowspan="1" colspan="1">52.1</td><td valign="middle" align="center" rowspan="1" colspan="1">0.12</td><td valign="middle" align="center" rowspan="1" colspan="1">1.6 (0.9-3.1)</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">LDL-cholesterol <xref ref-type="table-fn" rid="tfn10-cln_72p36">&#x000a7;</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">16.5</td><td valign="middle" align="center" rowspan="1" colspan="1">12.7</td><td valign="middle" align="center" rowspan="1" colspan="1">18.9</td><td valign="middle" align="center" rowspan="1" colspan="1">0.29</td><td valign="middle" align="center" rowspan="1" colspan="1">1.6 (0.6-3.9)</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Triglycerides <xref ref-type="table-fn" rid="tfn10-cln_72p36">&#x000a7;</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">23.6</td><td valign="middle" align="center" rowspan="1" colspan="1">15.4</td><td valign="middle" align="center" rowspan="1" colspan="1">29.2</td><td valign="middle" align="center" rowspan="1" colspan="1">0.04</td><td valign="middle" align="center" rowspan="1" colspan="1">2.3 (1.0-5.0)</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Glucose <xref ref-type="table-fn" rid="tfn10-cln_72p36">&#x000a7;</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">10.0</td><td valign="middle" align="center" rowspan="1" colspan="1">9.4</td><td valign="middle" align="center" rowspan="1" colspan="1">10.4</td><td valign="middle" align="center" rowspan="1" colspan="1">0.82</td><td valign="middle" align="center" rowspan="1" colspan="1">1.1 (0.4-3.3)</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Insulin <xref ref-type="table-fn" rid="tfn10-cln_72p36">&#x000a7;</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">36.9</td><td valign="middle" align="center" rowspan="1" colspan="1">23.1</td><td valign="middle" align="center" rowspan="1" colspan="1">46.3</td><td valign="middle" align="center" rowspan="1" colspan="1">0.002</td><td valign="middle" align="center" rowspan="1" colspan="1">2.9 (1.4-5.8)</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">HOMA-IR <xref ref-type="table-fn" rid="tfn10-cln_72p36">&#x000a7;</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">44.3</td><td valign="middle" align="center" rowspan="1" colspan="1">28.6</td><td valign="middle" align="center" rowspan="1" colspan="1">54.7</td><td valign="middle" align="center" rowspan="1" colspan="1">0.001</td><td valign="middle" align="center" rowspan="1" colspan="1">3.0 (1.5-5.9)</td></tr></tbody></table><table-wrap-foot><fn id="tfn9-cln_72p36"><p>Source: the author</p></fn><fn id="tfn10-cln_72p36"><label>&#x000a7;</label><p>Increased;</p></fn><fn id="tfn11-cln_72p36"><label>&#x003d5;</label><p>Reduced;</p></fn><fn id="tfn12-cln_72p36"><p>OR: odds ratio; 95% CI: 95% confidence interval.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t4-cln_72p36" position="float"><label>Table 4</label><caption><p>Simple linear correlation (<italic>r</italic>) between clinical, laboratory and leptin parameters in overweight and obese children and adolescents recruited from the public schools of the Municipality of Uberaba, Minas Gerais State, Brazil, from February 2013 to July 2014.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3" align="left" colspan="1">Variable</th><th colspan="6" align="center" rowspan="1">Variable</th></tr><tr><th colspan="2" align="center" rowspan="1">BMI</th><th colspan="2" align="center" rowspan="1">WC</th><th colspan="2" align="center" rowspan="1">Leptin</th></tr><tr><th align="center" rowspan="1" colspan="1"><italic>r</italic></th><th align="center" rowspan="1" colspan="1"><italic>p</italic></th><th align="center" rowspan="1" colspan="1"><italic>r</italic></th><th align="center" rowspan="1" colspan="1"><italic>p</italic></th><th align="center" rowspan="1" colspan="1"><italic>r</italic></th><th align="center" rowspan="1" colspan="1"><italic>p</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">BMI <xref ref-type="table-fn" rid="tfn14-cln_72p36">#</xref></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.89</td><td align="center" rowspan="1" colspan="1">0.001</td><td align="center" rowspan="1" colspan="1">0.69</td><td align="center" rowspan="1" colspan="1">0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI z-score <xref ref-type="table-fn" rid="tfn15-cln_72p36">&#x000a4;</xref></td><td align="center" rowspan="1" colspan="1">0.64</td><td align="center" rowspan="1" colspan="1">0.001</td><td align="center" rowspan="1" colspan="1">0.54</td><td align="center" rowspan="1" colspan="1">0.0001</td><td align="center" rowspan="1" colspan="1">0.47</td><td align="center" rowspan="1" colspan="1">0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">Waist circumference <xref ref-type="table-fn" rid="tfn14-cln_72p36">#</xref></td><td align="center" rowspan="1" colspan="1">0.89</td><td align="center" rowspan="1" colspan="1">0.001</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.68</td><td align="center" rowspan="1" colspan="1">0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">Body fat percentage <xref ref-type="table-fn" rid="tfn14-cln_72p36">#</xref></td><td align="center" rowspan="1" colspan="1">0.70</td><td align="center" rowspan="1" colspan="1">0.001</td><td align="center" rowspan="1" colspan="1">0.71</td><td align="center" rowspan="1" colspan="1">0.001</td><td align="center" rowspan="1" colspan="1">0.60</td><td align="center" rowspan="1" colspan="1">0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">Systolic blood pressure <xref ref-type="table-fn" rid="tfn14-cln_72p36">#</xref></td><td align="center" rowspan="1" colspan="1">0.53</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="center" rowspan="1" colspan="1">0.53</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="center" rowspan="1" colspan="1">0.36</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">Diastolic blood pressure <xref ref-type="table-fn" rid="tfn14-cln_72p36">#</xref></td><td align="center" rowspan="1" colspan="1">0.43</td><td align="center" rowspan="1" colspan="1">0.0001</td><td align="center" rowspan="1" colspan="1">0.43</td><td align="center" rowspan="1" colspan="1">0.001</td><td align="center" rowspan="1" colspan="1">0.29</td><td align="center" rowspan="1" colspan="1">0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">Total cholesterol <xref ref-type="table-fn" rid="tfn14-cln_72p36">#</xref></td><td align="center" rowspan="1" colspan="1">0.09</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">0.16</td><td align="center" rowspan="1" colspan="1">0.04</td><td align="center" rowspan="1" colspan="1">0.09</td><td align="center" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">HDL-cholesterol <xref ref-type="table-fn" rid="tfn14-cln_72p36">#</xref></td><td align="center" rowspan="1" colspan="1">-0.20</td><td align="center" rowspan="1" colspan="1">0.01</td><td align="center" rowspan="1" colspan="1">-0.20</td><td align="center" rowspan="1" colspan="1">0.006</td><td align="center" rowspan="1" colspan="1">-0.10</td><td align="center" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">LDL-cholesterol <xref ref-type="table-fn" rid="tfn14-cln_72p36">#</xref></td><td align="center" rowspan="1" colspan="1">0.13</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">0.18</td><td align="center" rowspan="1" colspan="1">0.03</td><td align="center" rowspan="1" colspan="1">0.08</td><td align="center" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">Triglycerides <xref ref-type="table-fn" rid="tfn15-cln_72p36">&#x000a4;</xref></td><td align="center" rowspan="1" colspan="1">0.20</td><td align="center" rowspan="1" colspan="1">0.01</td><td align="center" rowspan="1" colspan="1">0.23</td><td align="center" rowspan="1" colspan="1">0.003</td><td align="center" rowspan="1" colspan="1">0.20</td><td align="center" rowspan="1" colspan="1">0.014</td></tr><tr><td align="left" rowspan="1" colspan="1">TG/HDL-C <xref ref-type="table-fn" rid="tfn15-cln_72p36">&#x000a4;</xref></td><td align="center" rowspan="1" colspan="1">0.24</td><td align="center" rowspan="1" colspan="1">0.003</td><td align="center" rowspan="1" colspan="1">0.28</td><td align="center" rowspan="1" colspan="1">0.0003</td><td align="center" rowspan="1" colspan="1">0.21</td><td align="center" rowspan="1" colspan="1">0.009</td></tr><tr><td align="left" rowspan="1" colspan="1">Glucose <xref ref-type="table-fn" rid="tfn14-cln_72p36">#</xref></td><td align="center" rowspan="1" colspan="1">0.12</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">0.14</td><td align="center" rowspan="1" colspan="1">NS</td><td align="center" rowspan="1" colspan="1">0.13</td><td align="center" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">Insulin <xref ref-type="table-fn" rid="tfn15-cln_72p36">&#x000a4;</xref></td><td align="center" rowspan="1" colspan="1">0.52</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="center" rowspan="1" colspan="1">0.50</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="center" rowspan="1" colspan="1">0.39</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">HOMA-IR <xref ref-type="table-fn" rid="tfn15-cln_72p36">&#x000a4;</xref></td><td align="center" rowspan="1" colspan="1">0.54</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="center" rowspan="1" colspan="1">0.52</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="center" rowspan="1" colspan="1">0.40</td><td align="center" rowspan="1" colspan="1">0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">Leptin <xref ref-type="table-fn" rid="tfn14-cln_72p36">#</xref></td><td align="center" rowspan="1" colspan="1">0.69</td><td align="center" rowspan="1" colspan="1">0.001</td><td align="center" rowspan="1" colspan="1">0.68</td><td align="center" rowspan="1" colspan="1">0.0001</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="tfn13-cln_72p36"><p>Source: the author</p></fn><fn id="tfn14-cln_72p36"><label>#</label><p>Pearso&#x00144;s linear correlation coefficient</p></fn><fn id="tfn15-cln_72p36"><label>&#x000a4;</label><p>Spearma&#x00144;s linear correlation coefficient</p></fn><fn id="tfn16-cln_72p36"><p>NS: non-significant</p></fn></table-wrap-foot></table-wrap><table-wrap id="t5-cln_72p36" position="float"><label>Table 5</label><caption><p>Clinical and laboratory characterization of individuals with and without metabolic syndrome.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="left" colspan="1">Variable</th><th colspan="2" align="center" rowspan="1">METABOLIC SYNDROME</th><th rowspan="2" align="center" colspan="1"><italic>p</italic>-value</th></tr><tr><th valign="middle" align="center" rowspan="1" colspan="1">NO (n=139)</th><th valign="middle" align="center" rowspan="1" colspan="1">YES (n=22)</th></tr></thead><tbody><tr><td valign="middle" align="left" rowspan="1" colspan="1">Age (years) <xref ref-type="table-fn" rid="tfn18-cln_72p36">#</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">11.4&#x000b1;3.1</td><td valign="middle" align="center" rowspan="1" colspan="1">11.3&#x000b1;2.8</td><td valign="middle" align="center" rowspan="1" colspan="1">0.70</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Sex (M/F) <xref ref-type="table-fn" rid="tfn19-cln_72p36">&#x003d5;</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">50/89</td><td valign="middle" align="center" rowspan="1" colspan="1">8/14</td><td valign="middle" align="center" rowspan="1" colspan="1">0.97</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Pubertal stage(pre-pubertal/pubertal) <xref ref-type="table-fn" rid="tfn19-cln_72p36">&#x003d5;</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">53/86</td><td valign="middle" align="center" rowspan="1" colspan="1">11/11</td><td valign="middle" align="center" rowspan="1" colspan="1">0.29</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>) <xref ref-type="table-fn" rid="tfn18-cln_72p36">#</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">24.9&#x000b1;3.9</td><td valign="middle" align="center" rowspan="1" colspan="1">29.1&#x000b1;2.9</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">BMI z-score <xref ref-type="table-fn" rid="tfn18-cln_72p36">#</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">2.1&#x000b1;0.7</td><td valign="middle" align="center" rowspan="1" colspan="1">3.1&#x000b1;0.8</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Waist circumference (cm) <xref ref-type="table-fn" rid="tfn18-cln_72p36">#</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">78.0&#x000b1;10.6</td><td valign="middle" align="center" rowspan="1" colspan="1">89.9&#x000b1;8.8</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Body fat percentage <xref ref-type="table-fn" rid="tfn18-cln_72p36">#</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">37.9&#x000b1;8.6</td><td valign="middle" align="center" rowspan="1" colspan="1">50.9&#x000b1;8.0</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Systolic blood pressure (mmHg) <xref ref-type="table-fn" rid="tfn18-cln_72p36">#</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">106.6&#x000b1;9.2</td><td valign="middle" align="center" rowspan="1" colspan="1">115.3&#x000b1;11.5</td><td valign="middle" align="center" rowspan="1" colspan="1">0.0001</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Diastolic blood pressure (mmHg) <xref ref-type="table-fn" rid="tfn18-cln_72p36">#</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">68.4&#x000b1;7.2</td><td valign="middle" align="center" rowspan="1" colspan="1">77.6&#x000b1;6.9</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Total cholesterol (mg/dL) <xref ref-type="table-fn" rid="tfn18-cln_72p36">#</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">163.4&#x000b1;32.9</td><td valign="middle" align="center" rowspan="1" colspan="1">179.0&#x000b1;33.2</td><td valign="middle" align="center" rowspan="1" colspan="1">0.04</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">HDL-cholesterol (mg/dL) <xref ref-type="table-fn" rid="tfn18-cln_72p36">#</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">46.9&#x000b1;10.6</td><td valign="middle" align="center" rowspan="1" colspan="1">36.6&#x000b1;9.7</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">LDL-cholesterol (mg/dL) <xref ref-type="table-fn" rid="tfn18-cln_72p36">#</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">99.4&#x000b1;30.3</td><td valign="middle" align="center" rowspan="1" colspan="1">112.1&#x000b1;29.3</td><td valign="middle" align="center" rowspan="1" colspan="1">0.07</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Triglycerides (mg/dL) <xref ref-type="table-fn" rid="tfn18-cln_72p36">#</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">92.7&#x000b1;48.4</td><td valign="middle" align="center" rowspan="1" colspan="1">151.6&#x000b1;53.5</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">TG/HDL <xref ref-type="table-fn" rid="tfn20-cln_72p36">&#x000a4;</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">1.7 (0.6-10.4)</td><td valign="middle" align="center" rowspan="1" colspan="1">3.9 (2.0-9.9)</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Glucose (mg/dL) <xref ref-type="table-fn" rid="tfn18-cln_72p36">#</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">86.2&#x000b1;11.7</td><td valign="middle" align="center" rowspan="1" colspan="1">90.1&#x000b1;11.7</td><td valign="middle" align="center" rowspan="1" colspan="1">0.15</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Insulin (&#x000b5;IU/mL) <xref ref-type="table-fn" rid="tfn20-cln_72p36">&#x000a4;</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">12.4 (2.9-42.9)</td><td valign="middle" align="center" rowspan="1" colspan="1">20.6 (1.4-117.2)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.0002</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">HOMA-IR <xref ref-type="table-fn" rid="tfn20-cln_72p36">&#x000a4;</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">2.5 (0.5-11.6)</td><td valign="middle" align="center" rowspan="1" colspan="1">4.3 (0.3-28.7)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.0002</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Leptin (ng/mL) <xref ref-type="table-fn" rid="tfn18-cln_72p36">#</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">19.3&#x000b1;11.1</td><td valign="middle" align="center" rowspan="1" colspan="1">28.7&#x000b1;10.8</td><td valign="middle" align="center" rowspan="1" colspan="1">0.0003</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Adiponectin (ng/mL) <xref ref-type="table-fn" rid="tfn18-cln_72p36">#</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">10.7&#x000b1;15.1</td><td valign="middle" align="center" rowspan="1" colspan="1">10.1&#x000b1;12.1</td><td valign="middle" align="center" rowspan="1" colspan="1">0.86</td></tr></tbody></table><table-wrap-foot><fn id="tfn17-cln_72p36"><p>Source: the author</p></fn><fn id="tfn18-cln_72p36"><label>#</label><p><italic>t</italic>-test, values are expressed as the means &#x000b1; standard deviation;</p></fn><fn id="tfn19-cln_72p36"><label>&#x003d5;</label><p>Chi-squared test;</p></fn><fn id="tfn20-cln_72p36"><label>&#x000a4;</label><p>Mann-Whitney test, values are expressed as medians (Vmin-Vmax).</p></fn></table-wrap-foot></table-wrap></floats-group></article>